
- Pharmaceutical Technology, August 2023
- Volume 47
- Issue 8
- Pages: 12
Customizable mRNA Synthesis Service
Eurofins Genomics Blue Heron IVT mRNA synthesis service is designed to provide researchers a customizable solution.
Eurofins Genomics Blue Heron in-vitro transcription (IVT) messenger RNA (mRNA) synthesis service is designed to offer a comprehensive solution for researchers seeking high-quality, customizable mRNA synthesis with fast turnaround times. The synthesis service is intended for use in molecular biology, drug discovery, vaccine development, and gene therapy, among other fields.
The IVT mRNA synthesis service is designed to handle various applications and includes customizable mRNA synthesis capabilities to meet specific research needs. Researchers can customize mRNA transcripts in various ways, including modifying the sequence, length, and purity of the mRNA.
Articles in this issue
almost 3 years ago
Testing Innovative Analytical Watersalmost 3 years ago
Quality Quartets in Risk-Based Qualification: ICH Q9(R1) Considerationsalmost 3 years ago
Overcoming Challenges to Formulation Development for Pediatric Medicinesalmost 3 years ago
An Intelligent Drug Development Paradigmalmost 3 years ago
Charting the Future of Vaccinesalmost 3 years ago
Progressing Finished Product Inspection Through Automationalmost 3 years ago
Ensuring OSD Quality and Safetyalmost 3 years ago
A Healthier Tomorrow?almost 3 years ago
Phasing Out COVID-19 Regulatory Flexibilities



